Prospective, early, intensified controls of retinal thickness by optical coherence tomography to detect early recurrence of disease after treatment of degenerative and proliferative retinal diseases by intravitreal injection therapy

• Conditions: H35.3; Degeneration of macula and posterior pole

• Registration Number: DRKS00011705
• Lead Sponsor: Zentrum für AugenheilkundeUniklinik Köln

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2017-03-09
• Study Completion: 2018-05-01
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 41

Inclusion Criteria

Patients with indications for treatment of degenerative or proliferative maculopathy at the Centre for Ophthalmology , which also carry out the follow-up for recurrence detection at the site as well as willingness and consent to participate in the study

Exclusion Criteria

Physical or mental conditions which make the investigation for the patient appear unreasonable ( for example, severe dementia , severe immobility , limitation of movement in the cervical spine )

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Measurement of retinal thickness with optical coherence tomography (OCT) in micrometers on day 14, 21, 28 and 42 after intravitreal injection

Secondary Outcome Measures

Name	Time	Method
Identification of recurring CNV activity as identification of early recurrences by signs of activity in the OCT (subretinal fluid, intraretinal edema)